Trigen   Report issue

For profit Phase 1
Founded: Bridgewater NJ United States (2003)
Status: Acquired by Osmotica Pharmaceutical (2015)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 1 Trials (1)

Key: Trigen (0) Acquired (1)

revacept (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 1